Journal article
PsAID12 provisionally endorsed at OMERACT 2018 as core outcome measure to assess psoriatic arthritis-specific health-related quality of life in clinical trials
- Abstract:
-
Objective The Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA) and Outcome Measures in Rheumatology (OMERACT) psoriatic arthritis (PsA) working group is developing a Core Outcome Measurement Set for PsA clinical trials [randomized controlled trials (RCT) and longitudinal observational studies (LOS)] using the OMERACT Filter 2.1 instrument selection algorithm. Our objective was to assess the Psoriatic Arthritis Impact of Disease questionnaire ...
Expand abstract
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Access Document
- Files:
-
-
(Accepted manuscript, jpeg, 414.7KB)
-
(Accepted manuscript, jpeg, 120.9KB)
-
(Accepted manuscript, pdf, 106.2KB)
-
- Publisher copy:
- 10.3899/jrheum.181077
Authors
Bibliographic Details
- Publisher:
- Journal of Rheumatology Publishing Co. Ltd Publisher's website
- Journal:
- Journal of Rheumatology Journal website
- Volume:
- 45
- Issue:
- 12
- Pages:
- 1-6
- Publication date:
- 2018-12-15
- Acceptance date:
- 2018-11-06
- DOI:
- EISSN:
-
1499-2752
- ISSN:
-
0315-162X
Item Description
- Keywords:
- Pubs id:
-
pubs:938387
- UUID:
-
uuid:06703c36-e4a9-4ea3-9f92-e87d685474bb
- Local pid:
- pubs:938387
- Source identifiers:
-
938387
- Deposit date:
- 2018-11-06
Terms of use
- Copyright holder:
- The Journal of Rheumatology
- Copyright date:
- 2018
- Notes:
- © 2018 The Journal of Rheumatology. This is the accepted manuscript version of the article. The final version is available online from Journal of Rheumatology Publishing Co. Ltd at: https://doi.org/10.3899/jrheum.181077
Metrics
If you are the owner of this record, you can report an update to it here: Report update to this record